Firas Younis

479 total citations
13 papers, 392 citations indexed

About

Firas Younis is a scholar working on Molecular Biology, Surgery and Endocrine and Autonomic Systems. According to data from OpenAlex, Firas Younis has authored 13 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Surgery and 3 papers in Endocrine and Autonomic Systems. Recurrent topics in Firas Younis's work include Diabetes Treatment and Management (3 papers), Regulation of Appetite and Obesity (3 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Firas Younis is often cited by papers focused on Diabetes Treatment and Management (3 papers), Regulation of Appetite and Obesity (3 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Firas Younis collaborates with scholars based in Israel, Switzerland and Greece. Firas Younis's co-authors include Esther Shohami, Thomas Kossmann, Hans‐Pietro Eugster, O. Trentz, Philipp M. Lenzlinger, Vivianne I. Otto, Maria Cristina Morganti-Kossmann, Philip F. Stahel, Talma Rosenthal and Michal Horowitz and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Journal of Cerebral Blood Flow & Metabolism and European Journal of Pharmacology.

In The Last Decade

Firas Younis

12 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Firas Younis Israel 8 174 174 81 57 49 13 392
Saleena Alikunju United States 11 183 1.1× 96 0.6× 162 2.0× 51 0.9× 65 1.3× 15 485
Yue‐Yu Hu China 14 166 1.0× 139 0.8× 127 1.6× 101 1.8× 38 0.8× 19 428
Yanmei Yang China 11 130 0.7× 97 0.6× 62 0.8× 45 0.8× 23 0.5× 28 468
Hugo Rojas United States 10 128 0.7× 208 1.2× 134 1.7× 101 1.8× 68 1.4× 18 521
Tingqin Huang China 11 134 0.8× 91 0.5× 75 0.9× 55 1.0× 28 0.6× 29 333
Saidan Ding China 15 146 0.8× 54 0.3× 92 1.1× 75 1.3× 79 1.6× 29 467
Hisakazu Uno Japan 9 152 0.9× 59 0.3× 150 1.9× 46 0.8× 34 0.7× 15 441
Chao Lin China 13 386 2.2× 200 1.1× 85 1.0× 171 3.0× 68 1.4× 28 696
Yinan Zhao China 12 157 0.9× 88 0.5× 85 1.0× 34 0.6× 84 1.7× 32 426

Countries citing papers authored by Firas Younis

Since Specialization
Citations

This map shows the geographic impact of Firas Younis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Firas Younis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Firas Younis more than expected).

Fields of papers citing papers by Firas Younis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Firas Younis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Firas Younis. The network helps show where Firas Younis may publish in the future.

Co-authorship network of co-authors of Firas Younis

This figure shows the co-authorship network connecting the top 25 collaborators of Firas Younis. A scholar is included among the top collaborators of Firas Younis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Firas Younis. Firas Younis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
2.
Younis, Firas, Jonathan Leor, Zaid Abassi, et al.. (2018). Beneficial Effect of the SGLT2 Inhibitor Empagliflozin on Glucose Homeostasis and Cardiovascular Parameters in the Cohen Rosenthal Diabetic Hypertensive (CRDH) Rat. Journal of Cardiovascular Pharmacology and Therapeutics. 23(4). 358–371. 17 indexed citations
4.
Abassi, Zaid, Natalie Landa, Firas Younis, et al.. (2016). OS 05-04 EMPAGLIFLOZIN EXERTS CARDIO- AND NEPHRO-PROTECTIVE EFFECTS IN COHEN-ROSENTHAL DIABETIC HYPERTENSIVE RATS. Journal of Hypertension. 34(Supplement 1). e58–e59. 5 indexed citations
5.
Younis, Firas, et al.. (2014). Liver and kidney functions and blood minerals of Shami goats fed salt tolerant plants under the arid conditions of Southern Sinai, Egypt.. 10(3). 49–59. 3 indexed citations
6.
Younis, Firas, Yoram Oron, Rona Limor, Naftali Stern, & Talma Rosenthal. (2011). Prophylactic treatment with telmisartan induces tissue-specific gene modulation favoring normal glucose homeostasis in Cohen-Rosenthal diabetic hypertensive rats. Metabolism. 61(2). 164–174. 9 indexed citations
8.
Younis, Firas, David Mirelman, Aharon Rabinkov, & Talma Rosenthal. (2010). S‐Allyl‐Mercapto‐Captopril: A Novel Compound in the Treatment of Cohen‐Rosenthal Diabetic Hypertensive Rats. Journal of Clinical Hypertension. 12(6). 451–455. 11 indexed citations
9.
Rosenthal, Talma, Firas Younis, & Ariela Alter. (2010). Combating Combination of Hypertension and Diabetes in Different Rat Models. Pharmaceuticals. 3(4). 916–939. 6 indexed citations
10.
Younis, Firas, et al.. (2007). Telmisartan in the Treatment of Cohen-Rosenthal Diabetic Hypertensive Rats: The Benefit of PPAR-γ Agonism. Clinical and Experimental Hypertension. 29(6). 419–426. 8 indexed citations
12.
Stahel, Philip F., Esther Shohami, Firas Younis, et al.. (2000). Experimental Closed Head Injury: Analysis of Neurological Outcome, Blood–Brain Barrier Dysfunction, Intracranial Neutrophil Infiltration, and Neuronal Cell Death in Mice Deficient in Genes for Pro-Inflammatory Cytokines. Journal of Cerebral Blood Flow & Metabolism. 20(2). 369–380. 229 indexed citations
13.
Trembovler, Victoria, Elie Beit‐Yannai, Firas Younis, et al.. (1999). Antioxidants Attenuate Acute Toxicity of Tumor Necrosis Factor-alpha Induced by Brain Injury in Rat. Journal of Interferon & Cytokine Research. 19(7). 791–795. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026